Spinogenix
Clinical trials sponsored by Spinogenix, explained in plain language.
-
New ALS drug trial aims to slow disease progression
Disease control Not yet recruitingThis study tests whether tazbentetol can slow the decline in physical function for people with ALS. About 430 adults aged 18-80 with ALS will receive either the drug or a placebo. The main goal is to measure changes in daily living abilities and overall survival over time.
Phase: PHASE2, PHASE3 • Sponsor: Spinogenix • Aim: Disease control
Last updated May 17, 2026 22:12 UTC
-
New drug aims to boost brain function in fragile x patients
Symptom relief Not yet recruitingThis study tests a new drug called SPG601 to see if it can improve thinking and learning in adult men with Fragile X syndrome. About 248 men aged 18 to 45 will take either the drug or a placebo (a dummy pill) for several months. The main goal is to measure changes in cognitive ab…
Phase: PHASE2, PHASE3 • Sponsor: Spinogenix • Aim: Symptom relief
Last updated May 14, 2026 12:03 UTC